Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Clinical trials of prion disease therapeutics.

Forloni G, Roiter I, Tagliavini F.

Curr Opin Pharmacol. 2019 Feb;44:53-60. doi: 10.1016/j.coph.2019.04.019. Epub 2019 May 17. Review.

PMID:
31108459
2.

Alzheimer's Disease and Neurotransmission Gene Variants: Focus on Their Effects on Psychiatric Comorbidities and Inflammatory Parameters.

Porcelli S, Calabrò M, Crisafulli C, Politis A, Liappas I, Albani D, Raimondi I, Forloni G, Benedetti F, Papadimitriou GN, Serretti A.

Neuropsychobiology. 2019 May 16:1-7. doi: 10.1159/000497164. [Epub ahead of print]

PMID:
31096213
3.

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.

Marizzoni M, Ferrari C, Macis A, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Pizzini F, Rossini PM, Salvatore M, Schönknecht P, Soricelli A, Del Percio C, Hensch T, Hegerl U, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):49-58. doi: 10.3233/JAD-181016.

PMID:
30958351
4.

Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration.

Veneruso V, Rossi F, Villella A, Bena A, Forloni G, Veglianese P.

J Control Release. 2019 Apr 28;300:141-153. doi: 10.1016/j.jconrel.2019.02.038. Epub 2019 Mar 6. Review.

PMID:
30851286
5.

Nanovector-Mediated Drug Delivery in Spinal Cord Injury: A Multitarget Approach.

Papa S, Rossi F, Vismara I, Forloni G, Veglianese P.

ACS Chem Neurosci. 2019 Mar 20;10(3):1173-1182. doi: 10.1021/acschemneuro.8b00700. Epub 2019 Feb 25.

PMID:
30763071
6.

Review: PrP 106-126 - 25 years after.

Forloni G, Chiesa R, Bugiani O, Salmona M, Tagliavini F.

Neuropathol Appl Neurobiol. 2019 Jan 12. doi: 10.1111/nan.12538. [Epub ahead of print] Review.

PMID:
30635947
7.

Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects.

La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, Colombo L, Caldinelli L, Pollegioni L, Gobbi M, Chiesa R, Forloni G.

Brain. 2019 Feb 1;142(2):249-254. doi: 10.1093/brain/awy318.

PMID:
30601948
8.

Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.

Corponi F, Fabbri C, Boriani G, Diemberger I, Albani D, Forloni G, Serretti A.

Neuropsychobiology. 2019;77(2):67-72. doi: 10.1159/000493400. Epub 2018 Dec 13.

PMID:
30544110
9.

The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.

Calabrò M, Fabbri C, Crisafulli C, Albani D, Forloni G, Kasper S, Sidoti A, Velardi E, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Hum Psychopharmacol. 2018 Nov;33(6):e2682. doi: 10.1002/hup.2682. Epub 2018 Nov 13. No abstract available.

PMID:
30426571
10.

Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

Jovicich J, Babiloni C, Ferrari C, Marizzoni M, Moretti DV, Del Percio C, Lizio R, Lopez S, Galluzzi S, Albani D, Cavaliere L, Minati L, Didic M, Fiedler U, Forloni G, Hensch T, Molinuevo JL, Bartrés Faz D, Nobili F, Orlandi D, Parnetti L, Farotti L, Costa C, Payoux P, Rossini PM, Marra C, Schönknecht P, Soricelli A, Noce G, Salvatore M, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Frisoniand GB; and the PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):15-35. doi: 10.3233/JAD-180158.

PMID:
30400088
11.

Plasma and Brain Concentrations of Doxycycline after Single and Repeated Doses in Wild-Type and APP23 Mice.

Lucchetti J, Fracasso C, Balducci C, Passoni A, Forloni G, Salmona M, Gobbi M.

J Pharmacol Exp Ther. 2019 Jan;368(1):32-40. doi: 10.1124/jpet.118.252064. Epub 2018 Nov 5.

PMID:
30396916
12.

Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer's disease in a Family with Late-onset Dementia.

Artuso V, Benussi L, Ghidoni R, Moradi-Bachiller S, Fusco F, Curtolo S, Roiter I, Forloni G, Albani D.

Curr Alzheimer Res. 2019;16(1):1-7. doi: 10.2174/1567205015666181031150345.

PMID:
30381075
13.

Exome sequencing in an Italian family with Alzheimer's disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H.

Paracchini L, Beltrame L, Boeri L, Fusco F, Caffarra P, Marchini S, Albani D, Forloni G.

Alzheimers Res Ther. 2018 Oct 12;10(1):106. doi: 10.1186/s13195-018-0435-2.

14.

Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ.

Massimi L, Bukreeva I, Santamaria G, Fratini M, Corbelli A, Brun F, Fumagalli S, Maugeri L, Pacureanu A, Cloetens P, Pieroni N, Fiordaliso F, Forloni G, Uccelli A, Kerlero de Rosbo N, Balducci C, Cedola A.

Neuroimage. 2019 Jan 1;184:490-495. doi: 10.1016/j.neuroimage.2018.09.044. Epub 2018 Sep 18.

PMID:
30240904
15.

Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.

Albani D, Marizzoni M, Ferrari C, Fusco F, Boeri L, Raimondi I, Jovicich J, Babiloni C, Soricelli A, Lizio R, Galluzzi S, Cavaliere L, Didic M, Schönknecht P, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Bocchio L, Salvatore M, Rossini PM, Tsolaki M, Visser PJ, Richardson JC, Wiltfang J, Bordet R, Blin O, Forloni G, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):37-48. doi: 10.3233/JAD-180321.

PMID:
30149449
16.

Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models.

Balducci C, Santamaria G, La Vitola P, Brandi E, Grandi F, Viscomi AR, Beeg M, Gobbi M, Salmona M, Ottonello S, Forloni G.

Neurobiol Aging. 2018 Oct;70:128-139. doi: 10.1016/j.neurobiolaging.2018.06.002. Epub 2018 Jun 12.

PMID:
30007162
17.

Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease.

Tolomeo D, Micotti E, Serra SC, Chappell M, Snellman A, Forloni G.

Sci Rep. 2018 Jun 22;8(1):9576. doi: 10.1038/s41598-018-27839-7.

18.

Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

Marizzoni M, Ferrari C, Jovicich J, Albani D, Babiloni C, Cavaliere L, Didic M, Forloni G, Galluzzi S, Hoffmann KT, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ribaldi F, Rossini PM, Schönknecht P, Salvatore M, Soricelli A, Hensch T, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Alzheimers Dis. 2019;69(1):3-14. doi: 10.3233/JAD-180152.

PMID:
29914031
19.

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Papa S, Vismara I, Mariani A, Barilani M, Rimondo S, De Paola M, Panini N, Erba E, Mauri E, Rossi F, Forloni G, Lazzari L, Veglianese P.

J Control Release. 2018 May 28;278:49-56. doi: 10.1016/j.jconrel.2018.03.034. Epub 2018 Apr 3.

PMID:
29621597
20.

A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.

Silverman JM, Gibbs E, Peng X, Martens KM, Balducci C, Wang J, Yousefi M, Cowan CM, Lamour G, Louadi S, Ban Y, Robert J, Stukas S, Forloni G, Hsiung GR, Plotkin SS, Wellington CL, Cashman NR.

ACS Chem Neurosci. 2018 Jul 18;9(7):1591-1606. doi: 10.1021/acschemneuro.7b00469. Epub 2018 Apr 16.

PMID:
29614860
21.

Alzheimer's Disease, Oligomers, and Inflammation.

Forloni G, Balducci C.

J Alzheimers Dis. 2018;62(3):1261-1276. doi: 10.3233/JAD-170819. Review.

22.

Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2.

La Vitola P, Balducci C, Cerovic M, Santamaria G, Brandi E, Grandi F, Caldinelli L, Colombo L, Morgese MG, Trabace L, Pollegioni L, Albani D, Forloni G.

Brain Behav Immun. 2018 Mar;69:591-602. doi: 10.1016/j.bbi.2018.02.012. Epub 2018 Feb 16.

PMID:
29458199
23.

Novel targets in Alzheimer's disease: A special focus on microglia.

Balducci C, Forloni G.

Pharmacol Res. 2018 Apr;130:402-413. doi: 10.1016/j.phrs.2018.01.017. Epub 2018 Jan 31. Review.

PMID:
29391235
24.

Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model.

Carradori D, Balducci C, Re F, Brambilla D, Le Droumaguet B, Flores O, Gaudin A, Mura S, Forloni G, Ordoñez-Gutierrez L, Wandosell F, Masserini M, Couvreur P, Nicolas J, Andrieux K.

Nanomedicine. 2018 Feb;14(2):609-618. doi: 10.1016/j.nano.2017.12.006. Epub 2017 Dec 15.

PMID:
29248676
25.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Cristalli C, Mantovani V, Pae CU, Serretti A.

J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.

PMID:
29164477
26.

Single severe traumatic brain injury produces progressive pathology with ongoing contralateral white matter damage one year after injury.

Pischiutta F, Micotti E, Hay JR, Marongiu I, Sammali E, Tolomeo D, Vegliante G, Stocchetti N, Forloni G, De Simoni MG, Stewart W, Zanier ER.

Exp Neurol. 2018 Feb;300:167-178. doi: 10.1016/j.expneurol.2017.11.003. Epub 2017 Nov 7.

27.

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.

Fabbri C, Corponi F, Albani D, Raimondi I, Forloni G, Schruers K, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Cristalli CP, Mantovani V, Mendlewicz J, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:203-210. doi: 10.1016/j.pnpbp.2017.10.005. Epub 2017 Oct 6.

PMID:
28989100
28.

Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.

Chierchia A, Chirico N, Boeri L, Raimondi I, Riva GA, Raimondi MT, Tunesi M, Giordano C, Forloni G, Albani D.

Eur J Pharm Biopharm. 2017 Dec;121:113-120. doi: 10.1016/j.ejpb.2017.09.014. Epub 2017 Sep 28.

29.

Current Options for Cell Therapy in Spinal Cord Injury.

Vismara I, Papa S, Rossi F, Forloni G, Veglianese P.

Trends Mol Med. 2017 Sep;23(9):831-849. doi: 10.1016/j.molmed.2017.07.005. Epub 2017 Aug 12. Review.

PMID:
28811172
30.

Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F).

Del Percio C, Drinkenburg W, Lopez S, Limatola C, Bastlund JF, Christensen DZ, Pedersen JT, Forloni G, Frasca A, Noe FM, Bentivoglio M, Fabene PF, Bertini G, Colavito V, Dix S, Ferri R, Bordet R, Richardson JC, Babiloni C.

Curr Alzheimer Res. 2018;15(3):259-272. doi: 10.2174/1567205014666170704113405.

PMID:
28675996
31.

Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model.

Snellman A, Rokka J, López-Picón FR, Helin S, Re F, Löyttyniemi E, Pihlaja R, Forloni G, Salmona M, Masserini M, Solin O, Rinne JO, Haaparanta-Solin M.

Neurobiol Aging. 2017 Sep;57:84-94. doi: 10.1016/j.neurobiolaging.2017.05.008. Epub 2017 May 15.

32.

Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Mattiaccio A, Mantovani V, Jun TY, Pae CU, Serretti A.

Adv Ther. 2017 Jun;34(6):1482-1497. doi: 10.1007/s12325-017-0555-2. Epub 2017 May 16.

PMID:
28508933
33.

Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.

Mancini S, Balducci C, Micotti E, Tolomeo D, Forloni G, Masserini M, Re F.

J Control Release. 2017 Jul 28;258:121-129. doi: 10.1016/j.jconrel.2017.05.013. Epub 2017 May 10.

PMID:
28501671
34.

Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia.

Redaelli V, Bistaffa E, Zanusso G, Salzano G, Sacchetto L, Rossi M, De Luca CM, Di Bari M, Portaleone SM, Agrimi U, Legname G, Roiter I, Forloni G, Tagliavini F, Moda F.

Sci Rep. 2017 Apr 7;7:46269. doi: 10.1038/srep46269.

35.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):723-735. doi: 10.1007/s00406-017-0766-1. Epub 2017 Mar 4.

PMID:
28260126
36.

The role of single-nucleotide variants of the energy metabolism-linked genes SIRT3, PPARGC1A and APOE in amyotrophic lateral sclerosis risk.

Albani D, Pupillo E, Bianchi E, Chierchia A, Martines R, Forloni G, Beghi E.

Genes Genet Syst. 2017 May 13;91(6):301-309. doi: 10.1266/ggs.16-00023. Epub 2017 Feb 24.

37.

Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).

Nathan PJ, Lim YY, Abbott R, Galluzzi S, Marizzoni M, Babiloni C, Albani D, Bartres-Faz D, Didic M, Farotti L, Parnetti L, Salvadori N, Müller BW, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Payoux P, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

Neurobiol Aging. 2017 May;53:1-10. doi: 10.1016/j.neurobiolaging.2017.01.013. Epub 2017 Jan 18.

PMID:
28189924
38.

Corrigendum to 'Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease' [J. Neurol. Sci. 370 (November 2016) 162-166].

Porcelli S, Crisafulli C, Donato L, Calabrò M, Politis A, Liappas I, Albani D, Atti AR, Salfi R, Raimondi I, Forloni G, Papadimitriou GN, De Ronchi D, Serretti A.

J Neurol Sci. 2017 Jan 15;372:49. doi: 10.1016/j.jns.2016.11.031. Epub 2016 Nov 19. No abstract available.

PMID:
28017245
39.

Electrocardiogram Alterations Associated With Psychotropic Drug Use and CACNA1C Gene Variants in Three Independent Samples.

Fabbri C, Boriani G, Diemberger I, Filippi MG, Ravegnini G, Hrelia P, Minarini A, Albani D, Forloni G, Angelini S, Serretti A.

Basic Clin Pharmacol Toxicol. 2017 May;120(5):482-490. doi: 10.1111/bcpt.12720. Epub 2017 Jan 5.

40.

Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.

Gregori M, Taylor M, Salvati E, Re F, Mancini S, Balducci C, Forloni G, Zambelli V, Sesana S, Michael M, Michail C, Tinker-Mill C, Kolosov O, Sherer M, Harris S, Fullwood NJ, Masserini M, Allsop D.

Nanomedicine. 2017 Feb;13(2):723-732. doi: 10.1016/j.nano.2016.10.006. Epub 2016 Oct 19.

PMID:
27769888
41.

Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease.

Porcelli S, Crisafulli C, Donato L, Calabrò M, Politis A, Liappas I, Albani D, Atti AR, Salfi R, Raimondi I, Forloni G, Papadimitriou GN, De Ronchi D, Serretti A.

J Neurol Sci. 2016 Nov 15;370:162-166. doi: 10.1016/j.jns.2016.09.053. Epub 2016 Sep 28. Erratum in: J Neurol Sci. 2017 Jan 15;372:49.

PMID:
27772752
42.

Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.

Balducci C, Frasca A, Zotti M, La Vitola P, Mhillaj E, Grigoli E, Iacobellis M, Grandi F, Messa M, Colombo L, Molteni M, Trabace L, Rossetti C, Salmona M, Forloni G.

Brain Behav Immun. 2017 Feb;60:188-197. doi: 10.1016/j.bbi.2016.10.012. Epub 2016 Oct 14.

PMID:
27751869
43.

On-going electroencephalographic rhythms related to cortical arousal in wild-type mice: the effect of aging.

Del Percio C, Drinkenburg W, Lopez S, Infarinato F, Bastlund JF, Laursen B, Pedersen JT, Christensen DZ, Forloni G, Frasca A, Noè FM, Bentivoglio M, Fabene PF, Bertini G, Colavito V, Kelley J, Dix S, Richardson JC, Babiloni C; PharmaCog Consortium.

Neurobiol Aging. 2017 Jan;49:20-30. doi: 10.1016/j.neurobiolaging.2016.09.004. Epub 2016 Sep 15.

PMID:
27728831
44.

Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein-specific antibodies.

Höfling C, Morawski M, Zeitschel U, Zanier ER, Moschke K, Serdaroglu A, Canneva F, von Hörsten S, De Simoni MG, Forloni G, Jäger C, Kremmer E, Roßner S, Lichtenthaler SF, Kuhn PH.

Aging Cell. 2016 Oct;15(5):953-63. doi: 10.1111/acel.12508. Epub 2016 Jul 29.

45.

Association between Sirtuin 1 Gene rs10997870 Polymorphism and Suicide Behaviors in Bipolar Disorder.

Nivoli A, Porcelli S, Albani D, Forloni G, Fusco F, Colom F, Vieta E, Serretti A.

Neuropsychobiology. 2016;74(1):1-7. doi: 10.1159/000446921. Epub 2016 Jul 16.

PMID:
27424200
46.

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.

Stravalaci M, Tapella L, Beeg M, Rossi A, Joshi P, Pizzi E, Mazzanti M, Balducci C, Forloni G, Biasini E, Salmona M, Diomede L, Chiesa R, Gobbi M.

J Alzheimers Dis. 2016 Jul 6;53(4):1485-97. doi: 10.3233/JAD-150882.

47.

Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.

Biella G, Fusco F, Nardo E, Bernocchi O, Colombo A, Lichtenthaler SF, Forloni G, Albani D.

J Alzheimers Dis. 2016 Jun 30;53(3):1193-207. doi: 10.3233/JAD-151135.

PMID:
27372638
48.

CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.

Clarelli F, Mascia E, Santangelo R, Mazzeo S, Giacalone G, Galimberti D, Fusco F, Zuffi M, Fenoglio C, Franceschi M, Scarpini E, Forloni G, Magnani G, Comi G, Albani D, Martinelli Boneschi F.

J Alzheimers Dis. 2016 Apr 16;52(4):1203-8. doi: 10.3233/JAD-160074.

PMID:
27104904
49.

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.

Forloni G, Artuso V, La Vitola P, Balducci C.

Mov Disord. 2016 Jun;31(6):771-81. doi: 10.1002/mds.26624. Epub 2016 Mar 31. Review.

PMID:
27030592
50.

Loss of exosomes in progranulin-associated frontotemporal dementia.

Benussi L, Ciani M, Tonoli E, Morbin M, Palamara L, Albani D, Fusco F, Forloni G, Glionna M, Baco M, Paterlini A, Fostinelli S, Santini B, Galbiati E, Gagni P, Cretich M, Binetti G, Tagliavini F, Prosperi D, Chiari M, Ghidoni R.

Neurobiol Aging. 2016 Apr;40:41-49. doi: 10.1016/j.neurobiolaging.2016.01.001. Epub 2016 Jan 7.

PMID:
26973102

Supplemental Content

Loading ...
Support Center